Plasmodium yoelii nigeriensis (MDR) - Efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice

Experimental Parasitology

Volumn 94, Issue 3, 2000, Pages 190-193

  Tripathi, Renu ^a   Umesh, Aseem ^a   Mishra, Meenu ^a   Puri, S K ^a   Dutta, G P ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; DNA TOPOISOMERASE INHIBITOR; HALOFANTRINE; MEFLOQUINE; MEPACRINE; PYRONARIDINE; QUINIDINE; QUININE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIVITY; MALARIA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALIA; CINCHONA PUBESCENS; PLASMODIUM YOELII NIGERIENSIS; PROTOZOA;

EID: 0034029657     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1999.4470     Document Type: Article

References (21)

1. Bodley A. L., Cumming J. N., Shapiro T. A. Effect of camptothecin, a topoisomerase I inhibitor on Plasmodium falciparum. Biochemical Pharmacology. 55:1998;709-711.
2. Bunnag D., Viravan C., Looareesuwann S., Karbwang J., Harinasuta T. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand: A preliminary report. South East Asian Journal of Tropical Medicine & Public Health. 22:1991;380-385.
3. Chavalitschewinkoon P., Wilairat P., Gamage S., Denny W., Figgitt D., Ralph R. Structure activity relationships and modes of action of a-anilinoacridines against chloroquine resistant Plasmodium falciparum in vitro. Antimicrobial Agents & Chemotherapy. 37:1993;403-406.
4. Childs G. E., Hausler B., Milhous W., Chen C., Wimonwattrawatee T., Pooyindee N., Boudreau E. F. In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum. American Journal of Tropical Medicine Hygiene. 38:1988;24-29.
5. Dorn A., Vippagunta S. R., Matile H., Jaquet C., Vennerstrom J. L., Ridley R. G. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochemical Pharmacology. 55:1998;727-736.
6. Dutta G. P., Bajpai R., Vishwakarma R. A. Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis. Pharmacological Research. 21:1990;415-419.
7. Elueze E. I., Croft S. L., Warhurst D. C. Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro. Journal of Antimicrobial & Chemotherapy. 37:1996;511-518.
8. Fu S., Xiao S. X. Pyronaridine: A new antimalarial drug. Parasitology Today. 7:1991. 310-313.
9. Looareesuwan S., Kyle D. E., Viravan C., Vanijanonto S., Wilairatana P., Wernsdorfer W. H. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene. 54:1996;205-209.
10. Onori E., Majori G. Recent acquisitions on chemotherapy and chemoprophylaxis of malaria. Annual Ist Super Sanital. 25:1989;659-673.
11. Peters W., Robinson B. L. The chemotherapy of rodent malaria, XLVII. Studies on pyronaridine and other mannich base antimalarials. Annals of Tropical Medicine & Parasitology. 86:1992;455-465.
12. Pradines B., Tall A., Parzy D., Spiegal A., Fusai T., Hienne R., Trape J. F., Doury J. C. In vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents. Journal of Antimicrobial Chemotherapy. 42:1998;333-339.
13. Ringwald P., Bickii J., Basco L. K. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clinical Infectious Diseases. 26:1998;946-953.
14. Ringwald P., Bickii J., Basco L. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. The Lancet. 347:1996;24-28.
15. Shao B. R. A review of antimalarial drug pyronaridine. Chinese Medical Journal. 103:1990;428-434.
16. Valecha N., Gupta S., Devi V., Biswas S., Sharma A., Adak T., Asthana O. P., Sharma V. P. Efficacy of α/β arteether in acute uncomplicated P. falciparum malaria. International Journal of Clinical Pharmacology Research. 17:1997;11-15.
17. Winstanley P. Pyronaridine: A promising drug for Africa? Lancet. 347:1996;2-3.
18. Technical Report. 1984.
19. Wu L. J., Rabbege J. R., Nagasawa H., Jacobs G., Aikawa M. Morphological effects of pyronaridine on malarial parasites. American Journal of Tropical Medicine and Hygiene. 38:1988;30-36.
20. Yang H. L., Lin D. Q., Yang Y. M., Huang K. G., Dong Y., Yang P. F., Iao M. Z., Zhang C. Y. In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas. Southeast Asian Journal of Tropical Medicine and Public Health. 28:1997;460-463.
21. Zheng Z. Y., Chen C., Gao F. H., Zhu P. E., Guo H. Z. Synthesis of a new antimalarial drug pyronaridine, and its analogues. Acta Pharmacological Sinica. 17:1982;118-125.